Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-22-014974
Filing Date
2022-10-13
Accepted
2022-10-13 15:32:45
Documents
62
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A cydy-20220831x10qa.htm   iXBRL 10-Q/A 1642414
2 EX-31.1 cydy-20220831xex31d1.htm EX-31.1 9269
3 EX-31.2 cydy-20220831xex31d2.htm EX-31.2 9438
4 EX-32 cydy-20220831xex32.htm EX-32 6384
  Complete submission text file 0001558370-22-014974.txt   7401042

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20220831.xsd EX-101.SCH 65493
6 EX-101.CAL cydy-20220831_cal.xml EX-101.CAL 56280
7 EX-101.DEF cydy-20220831_def.xml EX-101.DEF 272462
8 EX-101.LAB cydy-20220831_lab.xml EX-101.LAB 432325
9 EX-101.PRE cydy-20220831_pre.xml EX-101.PRE 407078
56 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20220831x10qa_htm.xml XML 1234651
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q/A | Act: 34 | File No.: 000-49908 | Film No.: 221309054
SIC: 2834 Pharmaceutical Preparations